Список проголосовавших за комментарий " On The Wires<ul><li>WiLAN (<strong>WILN</strong>) announced patent license agreements with Nanya Technology Corporation — a leading memory solution provider for products embedded with consumer memory and low power memory who ranks among the top five global suppliers of dynamic random-access memory (DRAM). Terms not disclosed.</li><li>International Game Technology PLC (<strong>IGT</strong>) announced that its subsidiary, IGT Global Solutions Corporation will undertake a $15 million expansion to house a new, state-of-the-art instant ticket press at its Lakeland, Florida facility. The new servo-controlled TRESU press will increase IGT's printing capacity by approximately 30%.</li><li>Eagle Pharmaceuticals, Inc. (<strong>EGRX</strong>) announced that it has completed the submission of its 505(b)(2) NDA for Ryanodex for the treatment of exertional heat stroke to the FDA. There is no currently approved drug treatment for EHS. Due to the life-threatening nature of EHS and the unmet need for an effective drug treatment for EHS, Eagle has requested Priority Review of this NDA for Ryanodex. If granted, as anticipated, a Prescription Drug User Fee Act date for a decision on the NDA would be July 2017; otherwise the Company anticipates approval later in 2017.</li></ul>"